Opko Health OPK
$1.57 −$0.04 (-2.48%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.57 +0.04%
Open$1.57
Prev close$1.61
Day range$1.55 – $1.62
Volume3.52M
Market cap$1.17B
P/E (TTM)–
Dividend yield–
OPK Stock News
Headlines matching Opko Health or the OPK ticker, most recent first.
- Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH), Opko Health (OPK) and Zenas BioPharma, Inc. (ZBIO)
- H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
- Barrington Maintains Opko Health(OPK.US) With Hold Rating
- Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
- H.C. Wainwright Sticks to Their Buy Rating for Opko Health (OPK)
- Barrington Downgrades Opko Health(OPK.US) to Hold Rating Negative
- H.C. Wainwright Reaffirms Their Buy Rating on Opko Health (OPK)
- Barrington Maintains Opko Health(OPK.US) With Buy Rating, Cuts Target Price to $1.5 Negative
- Earnings Flash (OPK) OPKO Health, Inc. Reports Q3 Revenue $65.4M, Vs. FactSet Est of $136.6M
- Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $4
- GUIDANCE: (OPK) OPKO Health, Inc. Expects Q4 Revenue Range $62.0M - $72.0M
- H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
- H.C. Wainwright Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3
- Barrington Upgrades Opko Health(OPK.US) to Buy Rating, Announces Target Price $2.25 Positive
- Analysts Offer Insights on Healthcare Companies: Opko Health (OPK) and Adlai Nortye Ltd. Sponsored ADR (ANL)
No comments yet — be the first to weigh in on OPK.
Sign in to join the discussion.